Switching Human Serum Supplier — The 7 Criteria That Actually Matter
Whether you are moving because of supply issues, documentation gaps, pricing, or regulatory requirements — switching human serum is not a decision to take lightly. This guide covers the seven criteria experienced IVD developers and cell culture teams use to evaluate and qualify a new supplier.
Donor Origin & Regulatory Framework
For European IVD manufacturers under EU IVDR 2017/746, donor origin directly affects regulatory documentation. EU-qualified donors processed under EU Blood Directive 2002/98/EC provide the cleanest path through your technical file. US-origin material is not disqualified — but requires additional justification in a European regulatory submission.
Ask your supplier: "What country are your donors from and under which regulatory framework are they qualified?"Donor Screening Panel
Minimum screening must include HIV 1/2 (antibody and NAT), HBsAg, anti-HCV (and HCV RNA), syphilis and HTLV I/II where applicable. For IVD applications, request the full screening certificate — not just a CoA summary. Extended panels (HAV, HEV, B19 parvovirus) are relevant for specific assay types.
Ask your supplier: "Can you provide the full donor screening panel with NAT results for each lot?"Lot-to-Lot Consistency & Batch Reservation
Human serum is a biological material — inherent lot variability is unavoidable. The question is how your supplier manages it. Batch reservation — the ability to reserve a validated lot and call it off over time — is the single most important operational tool for managing consistency in long-term projects.
Ask your supplier: "Can I reserve a specific lot without prepayment and call it off in partial deliveries?"Documentation Quality
A CoA is the minimum. For IVD development and GMP applications you also need: origin certificate, donor screening records, sterility test results, processing batch records, and ideally a technical file or DMF number for regulatory submissions. Suppliers who cannot provide this within 48 hours are a red flag.
Ask your supplier: "What documentation do you supply per lot, and what is available on request?"Processing Options & Variants
Native, heat inactivated, delipidated, IgG-depleted, charcoal stripped, gamma irradiated — the range of processing options determines whether a supplier can serve your full application portfolio or only part of it. Sourcing multiple variants from a single supplier reduces qualification burden.
Ask your supplier: "Which processing variants do you have in stock vs. available on request, and what are lead times?"Volume Flexibility & No Minimum Orders
Development teams need small quantities for method development and validation. Production teams need reliable large-volume supply. A supplier that requires large minimum orders forces overstocking or dual-sourcing. No minimum order quantity with flexible volume options is the ideal setup for both phases.
Ask your supplier: "What is the minimum order quantity, and can I order 100 mL for initial validation?"Supply Security & Lead Times
Human serum supply depends on donor availability. Supply disruptions are more common than anticipated — particularly for rare formats like delipidated, IgG-free, or male-only serum. A supplier with EU stock, short lead times, and clear batch reservation policy significantly reduces supply chain risk.
Ask your supplier: "Where is the stock held, what are typical lead times, and what happens if my reserved lot runs out?"Personal Service & Technical Support
A named contact who answers technical questions, understands your application, and resolves supply issues directly — without call centres or ticket systems — is not a luxury in a regulated supply chain. It is a risk management tool.
SeamlessBio: direct contact in Passau · info@seamlessbio.de · +49 851 37932226Supplier Switching Checklist — Before You Commit
Request test samples of at least 2 different lots — not just 1. Single-lot evaluation does not reveal batch variability.
Run a parallelism study — test new supplier lot against your current validated lot side-by-side in your assay or cell culture system.
Define acceptance criteria before testing — not after. Minimum cell growth %, maximum CV between lots, minimum analyte recovery in your assay.
Request full documentation upfront — CoA, donor screening, origin certificate. If the supplier hesitates, that tells you something.
Clarify batch reservation terms — volume, timeline, prepayment requirements, what happens if the reserved lot is exhausted.
Overlap your supply — maintain sufficient stock of the old lot during validation of the new lot. Never switch mid-project without a validated alternative.
Document the switch — for GMP and IVD applications, a supplier change is a documented change control event. Prepare your comparability report before initiating the switch.
Which Criteria Matter Most — By Application
| Anwendung | Most Critical Criteria | Key Format |
|---|---|---|
| CAR-T / ATMP manufacturing | EU origin, GMP documentation, lot reservation, xeno-free path | Humanes Serum AB OTC, männlich |
| IVD assay development | Donor screening documentation, lot consistency, matrix matching | Universal Negative, Delipidated |
| Lipemia interference studies | Delipidation method, residual lipid specification, CLSI EP7 | Delipidated Human Serum |
| Hormone / steroid assays | Charcoal stripping completeness, hormone-free certificate | Double Charcoal Treated |
| Malaria / P. falciparum culture | Type AB mandatory, lot qualification by parasitaemia assay | Human-Serum-AB OTC |
| Hybridoma production | Complement inactivation, IgG background level | Humanes Serum AB HI |
| MSC expansion (clinical) | Xeno-free, EU origin, GMP documentation, lot reservation | Human Serum AB or hPL |
Why labs switch to SeamlessBio for human serum
- EU-qualified donors — processed under EU Blood Directive 2002/98/EC, directly relevant for IVDR technical documentation
- Batch reservation without prepayment — reserve your validated lot, call off in partial deliveries as needed
- No minimum order quantity — 100 mL for validation, bulk for production — same supplier, same lot
- Full documentation per lot — CoA, donor screening records, origin certificate, viral testing panel
- Full portfolio — native, heat inactivated, delipidated, Universal Negative, hPL — all from EU donors
- Direct contact — personal support from Passau, no call centre, no ticket system
Häufig gestellte Fragen
Ready to Evaluate SeamlessBio Human Serum?
Free test samples, no minimum order, batch reservation without prepayment. EU stock in Passau — fast delivery across EU and UK. Response within 1 business day.
E-Mail: info@seamlessbio.de | +49 851 37932226
English 
Deutsch